Literature DB >> 30506808

Outcomes after lung transplantation for patients with occupational lung diseases.

Kyla D Joubert1, J Awori Hayanga2, Diane C Strollo1, Elizabeth A Lendermon3, Samuel A Yousem4, James D Luketich1, Christopher R Ensor5, Norihisa Shigemura6.   

Abstract

Occupational lung diseases (OLD) including silicosis, asbestosis, and pneumoconiosis progress to end stage lung disease requiring lung transplantation (LT). Prognosis and treatment of OLDs are poorly understood and a paucity of data exists regarding LT outcomes. Additionally, transplant operative complexity for patients with OLD is high. A single center retrospective review of all single and bilateral LT recipients between May 2005 and Oct 2016 was performed. Patients were grouped by OLD, and nearest neighbor matching was performed at a ratio of 1:3 cases to controls. Thirty cases were matched to 88 controls. Seventeen patients (57%) with OLD required intraoperative support with either extra-corporeal membrane oxygenation (ECMO) or cardiopulmonary bypass (P = 0.02), and 5 (17%) required delayed chest closure (P = 0.05) which was more frequent than matched controls. In addition, operative time was significantly longer in patients with OLD (P = 0.03). Despite these factors, there were no significant differences in immediate post-operative outcomes including mechanical ventilator support, post-operative ECMO, and tracheostomy. Chronic lung allograft dysfunction and long-term survival were also similar between cases and controls. OLDs should not preclude LT. The operation should be performed at experienced centers.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  asbestosis; pneumoconiosis; silicosis

Mesh:

Year:  2018        PMID: 30506808     DOI: 10.1111/ctr.13460

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  2 in total

Review 1.  Current Review of Pneumoconiosis Among US Coal Miners.

Authors:  Noemi B Hall; David J Blackley; Cara N Halldin; A Scott Laney
Journal:  Curr Environ Health Rep       Date:  2019-09

2.  Hesperetin attenuates silica-induced lung injury by reducing oxidative damage and inflammatory response.

Authors:  Shuxian Li; Linlin Shao; Jinguo Fang; Juan Zhang; Yanqin Chen; Abrey J Yeo; Martin F Lavin; Gongchang Yu; Hua Shao
Journal:  Exp Ther Med       Date:  2021-01-28       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.